• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket

    1/25/23 7:48:04 AM ET
    $ARDS
    $ASAP
    $COCP
    $CRKN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ARDS alert in real time by email

    Gainers

    • Inpixon (NASDAQ:INPX) shares rose 41% to $2.20 in pre-market trading after gaining 6% on Tuesday. Inpixon, last month, secured a purchase order valued at over $1m for its RTLS products from a leading transportation and industrial equipment provider.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) rose 36.7% to $0.2161 in pre-market trading after jumping 88% on Tuesday. The company, last month, named Alex Igelman as Chief Executive Officer.
    • eHealth, Inc. (NASDAQ:EHTH) rose 18.5% to $6.43 in pre-market trading after the company raised its preliminary FY22 revenue guidance.
    • Novo Integrated Sciences, Inc. (NASDAQ:NVOS) shares rose 16.6% to $0.1539 in pre-market trading after gaining 7% on Tuesday. Novo Integrated Sciences recently entered an agreement to purchase 100% of shares of SWAG in exchange for $1.00.
    • Aridis Pharmaceuticals, Inc. (NASDAQ:ARDS) rose 13.1% to $0.9498 in pre-market trading after dropping 28% on Tuesday.
    • enCore Energy Corp. (NYSE:EU) rose 9.3% to $2.95 in pre-market trading after the company announced a proposed public offering.
    • Society Pass Incorporated (NASDAQ:SOPA) rose 8.4% to $1.08 in pre-market trading. Society Pass, last month, acquired More Media.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) rose 8.1% to $0.2702 in pre-market trading. Crown Electrokinetics recently announced it acquired Amerigen 7.
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) shares rose 7.7% to $5.35 in pre-market trading. Rocket Lab successfully launched its 33rd Electron rocket and first mission from Virginia.
    • Incannex Healthcare Limited (NASDAQ:IXHL) rose 7.7% to $3.45 in pre-market trading after dropping 10% on Tuesday.

    Losers

    • ASAP, Inc. (NASDAQ:ASAP) fell 26.1% to $0.43 in pre-market trading. ASAP.com & Chipotle Mexican Grill, during November, signed a major food delivery agreement.
    • Precigen, Inc. (NASDAQ:PGEN) shares fell 18.3% to $1.79 in pre-market trading after the company reported pricing of $75.0 million public offering of common stock.
    • Grom Social Enterprises, Inc. (NASDAQ:GROM) fell 12.4% to $2.80 in pre-market trading after jumping 44% on Tuesday.
    • PolyPid Ltd. (NASDAQ:PYPD) fell 11.1% to $0.96 in pre-market trading. PolyPid shares gained 10% on Tuesday after the company said following a recent type D meeting communication with the FDA on the SHIELD I Phase 3 data, it now has clarity regarding the regulatory pathway toward a potential NDA submission.
    • Helbiz, Inc. (NASDAQ:HLBZ) shares dropped 10.3% to $0.3671 in pre-market trading. Helbiz, on Tuesday, announced over 1300 pre-orders generating over $2.2 million in future sales.
    • Cocrystal Pharma, Inc. (NASDAQ:COCP) fell 8.3% to $2.53 in pre-market trading after adding 18% on Tuesday. HC Wainwright & Co. maintained Cocrystal Pharma with a Buy and lowered the price target from $42 to $35.
    • Intuitive Surgical, Inc. (NASDAQ:ISRG) fell 7.7% to $237.90 in pre-market after the company reported weaker-than-expected results for its fourth quarter on Tuesday.
    • Satixfy Communications Ltd. (NASDAQ:SATX) fell 7% to $2.13 in pre-market trading after dropping 68% on Tuesday. SatixFy Communications recently appinted Mr. Ido Gur as Chief Executive Officer.
    • MicroCloud Hologram Inc. (NASDAQ:HOLO) shares fell 6.3% to $11.70 in pre-market trading after declining around 4% on Tuesday.
    • NeuBase Therapeutics, Inc. (NASDAQ:NBSE) fell 6.3% to $0.24 in pre-market trading after dropping over 5% on Tuesday.

    Now Read This: Tesla, Boeing And 3 Stocks To Watch Heading Into Wednesday

    Get the next $ARDS alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARDS
    $ASAP
    $COCP
    $CRKN

    CompanyDatePrice TargetRatingAnalyst
    Intuitive Surgical Inc.
    $ISRG
    3/11/2026$590.00Neutral → Buy
    Citigroup
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Intuitive Surgical Inc.
    $ISRG
    1/27/2026$660.00Buy
    TD Cowen
    Rocket Lab Corporation
    $RKLB
    1/16/2026$105.00Equal-Weight → Overweight
    Morgan Stanley
    Rocket Lab Corporation
    $RKLB
    1/15/2026Overweight → Sector Weight
    KeyBanc Capital Markets
    enCore Energy Corp.
    $EU
    1/6/2026$3.50Outperform
    Northland Capital
    Intuitive Surgical Inc.
    $ISRG
    12/11/2025$635.00Buy → Neutral
    Citigroup
    Rocket Lab Corporation
    $RKLB
    11/12/2025$55.00 → $63.00Buy
    Needham
    More analyst ratings

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Intuitive Surgical upgraded by Citigroup with a new price target

    Citigroup upgraded Intuitive Surgical from Neutral to Buy and set a new price target of $590.00

    3/11/26 8:28:54 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    eHealth downgraded by Craig Hallum with a new price target

    Craig Hallum downgraded eHealth from Buy to Hold and set a new price target of $2.00

    2/26/26 8:34:26 AM ET
    $EHTH
    Specialty Insurers
    Finance

    TD Cowen initiated coverage on Intuitive Surgical with a new price target

    TD Cowen initiated coverage of Intuitive Surgical with a rating of Buy and set a new price target of $660.00

    1/27/26 8:46:58 AM ET
    $ISRG
    Industrial Specialties
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Capital Is Repricing North American Critical Minerals: What Comes Next

    VANCOUVER, British Columbia, March 17, 2026 (GLOBE NEWSWIRE) -- USANewsGroup.com Sector Commentary — The structural realignment in critical minerals supply chains is no longer a forecast; it is an allocation event. A February 2026 analysis from the Critical Minerals Institute[1] framed the shift plainly: the IEA projects a 30% copper supply shortfall by 2035, rare earth supplies outside China cover less than 40% of projected demand, and Western governments are now deploying price floors and structured offtake frameworks to keep non-China production investable. Days earlier, the White House announced Project Vault, a $12 billion strategic minerals stockpile pairing US Export-Import Bank fin

    3/17/26 11:24:20 AM ET
    $APD
    $EU
    Major Chemicals
    Basic Materials
    Other Metals and Minerals

    PolyPid Receives PDUFA Fee Waiver from FDA for D-PLEX₁₀₀'s New Drug Application

    FDA Grants $4.3 Million Small Business Waiver, Enabling Focus on Commercialization Preparations Company On Track to Initiate NDA Submission by the End of this Month PETACH TIKVA, Israel, March 17, 2026 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), an innovative biopharmaceutical company dedicated to improving patient outcomes by elevating treatment effectiveness, right where care begins, today announced that the U.S. Food and Drug Administration (FDA) has granted a small business waiver of the Prescription Drug User Fee Act (PDUFA) fee of approximately $4.3 million for the New Drug Application (NDA) for D-PLEX₁₀₀, the Company's lead product candidate for th

    3/17/26 8:30:00 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Incannex Regains Compliance with Nasdaq Minimum Bid Price Requirement

    MELBOURNE, Australia and NEW YORK, March 17, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today announced that it has regained compliance with the Nasdaq minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company received written confirmation from The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement after its common stock maintained a closing bid price of $1.00 per share or greater for eleven consecutive business days, from February 27 through March 13, 2026. As a result, the Company has satisfied t

    3/17/26 8:00:00 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Dolan John Joseph bought $38,190 worth of shares (25,000 units at $1.53), increasing direct ownership by 14% to 208,755 units (SEC Form 4)

    4 - eHealth, Inc. (0001333493) (Issuer)

    3/9/26 4:03:37 PM ET
    $EHTH
    Specialty Insurers
    Finance

    Chief Executive Officer Duke Derrick A bought $259,397 worth of shares (187,969 units at $1.38), increasing direct ownership by 63% to 487,969 units (SEC Form 4)

    4 - eHealth, Inc. (0001333493) (Issuer)

    3/2/26 4:13:31 PM ET
    $EHTH
    Specialty Insurers
    Finance

    Director Frost Phillip Md Et Al bought $19,952 worth of shares (20,000 units at $1.00) (SEC Form 4)

    4 - Cocrystal Pharma, Inc. (0001412486) (Issuer)

    2/25/26 4:10:11 PM ET
    $COCP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Kirk Randal J converted options into 143,678 shares (SEC Form 4)

    4 - PRECIGEN, INC. (0001356090) (Issuer)

    3/16/26 5:29:37 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Agee Nancy H converted options into 71,839 shares, increasing direct ownership by 31% to 305,776 units (SEC Form 4)

    4 - PRECIGEN, INC. (0001356090) (Issuer)

    3/16/26 5:14:03 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Alvarez Cesar L converted options into 71,839 shares, increasing direct ownership by 10% to 782,909 units (SEC Form 4)

    4 - PRECIGEN, INC. (0001356090) (Issuer)

    3/16/26 5:12:59 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    SEC Filings

    View All

    Rocket Lab Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Rocket Lab Corp (0001819994) (Filer)

    3/17/26 4:26:06 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    SEC Form 424B5 filed by Rocket Lab Corporation

    424B5 - Rocket Lab Corp (0001819994) (Filer)

    3/17/26 4:24:03 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Incannex Healthcare Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial Statements and Exhibits

    8-K - Incannex Healthcare Inc. (0001873875) (Filer)

    3/17/26 8:00:21 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Leadership Updates

    Live Leadership Updates

    View All

    William M. Sheriff Appointed as Executive Chair of Verdera Energy

    TSX-V:V www.verderauranium.comVANCOUVER, BC, March 2, 2026 /CNW/ - Verdera Energy Corp. (TSXV:V) ("Verdera" or the "Company") announced today the appointment of Mr. William M. Sheriff as Executive Chair and a Director of Verdera Energy Corp. Mr. Sheriff previously served as Executive Chair of enCore Energy Corp. (NASDAQ:EU) (TSXV:EU) which is the largest shareholder of Verdera Energy Corp. William M. SheriffMr. Sheriff is an entrepreneur and visionary with over 40 years of experience in the minerals industry and the securities industry. Mr. Sheriff was the founder and Executive

    3/2/26 7:00:00 AM ET
    $EU
    Other Metals and Minerals
    Basic Materials

    Incannex Healthcare Announces Additional Appointments to Clinical Advisory Board

    MELBOURNE, Australia and NEW YORK, Jan. 29, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced the appointment of three additional members to its recently established Clinical Advisory Board ("CAB"): Murray B. Stein, MD, MPH; Andrew Cutler, MD; and Amir Kalali, MD. The CAB was formed to provide independent clinical and scientific guidance as the Company progresses PSX-001 into its next phase of clinical and regulatory development. The addition of Drs. Stein, Cutler, and Kalali further strengthens the Board's expertise across psychiatry, neurobiology, psychopharmacology, an

    1/29/26 8:00:00 AM ET
    $IXHL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors

    PETACH TIKVA, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (NASDAQ:PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced the appointment of Brooke Story as Chairman of the Board of Directors, effective as of December 11, 2025. "Brooke's appointment marks an exciting and pivotal moment for PolyPid," said Dikla Czaczkes Akselbrad, Chief Executive Officer of PolyPid. "Her global expertise in the surgical market, specifically in infection prevention and advanced surgical solutions, combined with her extensive experience leading corporate strategy and corporate development transactions, will be instrumental in transfor

    12/16/25 8:30:00 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Financials

    Live finance-specific insights

    View All

    Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25

    GERMANTOWN, Md., March 11, 2026 /PRNewswire/ -- Precigen, Inc. (NASDAQ:PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve the lives of patients, today announced the Company will release full year 2025 financial results and provide business updates on Wednesday, March 25, 2026. The Company will host a conference call to discuss results that day at 4:30 PM ET. The conference call may be accessed by dialing 1-800-836-8184 (North America) or 1-646-357-8785 (International). Participants are asked to dial in

    3/11/26 4:05:00 PM ET
    $PGEN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rocket Lab Establishes New Precision Machining Complex, Expands Manufacturing Footprint with Acquisition of Precision Components Ltd

    LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB), a global leader in launch and space systems, today announced the acquisition of Precision Components Limited (PCL) in Auckland, New Zealand, expanding Rocket Lab's high volume, precision manufacturing capabilities. The newly acquired facility will be established as the Auckland Machine Complex, dedicated to the production of high-tech, high-tolerance machined components and engineering service for the global aerospace industry. The new facility will play a pivotal role in the high-volume manufacturing of components for Rocket Lab's spacecraft customers, support the continued acceleration of Electro

    2/26/26 4:09:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    Rocket Lab Acquires Optical Support, Inc., Strengthening National Security Payload Capability

    LONG BEACH, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Rocket Lab Corporation (NASDAQ:RKLB) ("Rocket Lab" or the "Company"), a global leader in launch services and space systems, today announced it has completed the acquisition of Optical Support, Inc. (OSI), a leader in the design, engineering, and manufacturing of custom, high-precision optical and optomechanical instruments. OSI's advanced lenses and optomechanical systems are critical enablers for national security and commercial satellites, and are key subsystems used in Rocket Lab Optical Systems' high-performance payloads for space protection, space domain awareness, missile warning, tracking and defense. OSI delivers end-to-end solu

    2/26/26 4:06:00 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $ARDS
    $ASAP
    $COCP
    $CRKN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by PolyPid Ltd.

    SC 13G/A - PolyPid Ltd. (0001611842) (Subject)

    12/12/24 7:05:07 AM ET
    $PYPD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by enCore Energy Corp.

    SC 13G - enCore Energy Corp. (0001500881) (Subject)

    12/11/24 11:30:47 AM ET
    $EU
    Other Metals and Minerals
    Basic Materials

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials